PARP Inhibitor Combinations and Future of Ovarian Cancer

preview_player
Показать описание
Matthew A. Powell, MD, comments on the novel PARP inhibitor–containing combinations that are most promising and the outlook for ovarian cancer treatment.

  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
PARP Inhibitor Combinations 0:01:58

PARP Inhibitor Combinations and Future of Ovarian Cancer

PARP Combinations: The 0:04:49

PARP Combinations: The Future

Future Role of 0:04:59

Future Role of PARP Inhibition in BRCA+ Breast Cancer

Ongoing Clinical Trials 0:18:37

Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer

Combinations With PARP 0:06:25

Combinations With PARP Inhibitors for Ovarian Cancer

Ready for Prime 2:48:58

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combination...

PARP Inhibitors in 0:54:40

PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry Genetics

PARP Inhibitor Combination 0:35:38

PARP Inhibitor Combination Regimens for Prostate Cancer Management

Evaluating future use 0:00:45

Evaluating future use of PARP inhibitors in neoadjuvant therapy for ovarian cancer

The Future Role 0:03:44

The Future Role of PARP Inhibition in Ovarian Cancer

PARP inhibitors in 0:59:14

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023

Dr. Backes Discusses 0:01:11

Dr. Backes Discusses PARP Inhibitor Combinations in Ovarian Cancer

Ready for Prime 2:48:58

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combination...

Dr. Hardesty on 0:01:40

Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer

Future of PARP 0:03:34

Future of PARP Inhibitors in mCRPC

Combinations May Combat 0:00:49

Combinations May Combat PARP Resistance

Future possibilities of 0:15:23

Future possibilities of PARP-inhibition in the case of disturbance of homologous recombination

Advanced Breast Cancer: 0:46:00

Advanced Breast Cancer: Challenges in Pathways Development

PARP Inhibitors: New 0:22:23

PARP Inhibitors: New Insights & Future of Ovarian Cancer Treatment

Looking to the 0:01:21

Looking to the Future of PARP Inhibitors in CRPC

Future of PARP 0:02:20

Future of PARP inhibitors for urothelial carcinoma

LuPARP: 177Lu-PSMA-617 and 0:01:24

LuPARP: 177Lu-PSMA-617 and PARP inhibitor combination for prostate cancer

Questions That Remain 0:02:04

Questions That Remain Regarding Combination, Sequencing With PARP Inhibitors

Dr. Levine on 0:00:56

Dr. Levine on Combos With PARP Inhibitors in Ovarian Cancer